Haemonetics Corporation (HAE) Balance Sheet

The balance sheet has shifted from a conservative posture to one with meaningfully higher leverage, likely reflecting the OpSens acquisition and other strategic investments. While equity has remained relatively stable around $800-900M, the absolute debt increase of roughly $400M suggests a deliberate use of debt to fund growth. This trajectory implies that management is comfortable taking on leverage to pivot the portfolio, but investors should monitor whether the incremental debt generates sufficient returns to justify the higher financial risk.

The jump in leverage coincides with the OpSens acquisition, indicating that debt was used to finance inorganic growth rather than operational necessity. The D/E ratio of 1.40 is elevated relative to peers like Teleflex (0.87) and Hologic (0.52), suggesting a more aggressive capital structure. While the company's current ratio of 3.08 provides a liquidity cushion, the fixed interest burden could pressure earnings if cash flows falter, especially given the persistent TTM revenue decline.

The rise in goodwill reflects the OpSens acquisition and other deals, indicating that a growing portion of the asset base is intangible and subject to impairment risk. In contrast, net PPE has stayed relatively stable, suggesting that the company is not investing heavily in new manufacturing capacity but rather in software and placed equipment. This asset mix implies a shift toward a more asset-light model, but the increasing goodwill balance warrants monitoring for potential write-downs if growth initiatives underperform.

The decline in retained earnings over the past two years is notable, as it suggests that cumulative dividends or losses have exceeded net income, or that there have been significant adjustments. Given that the company does not pay a dividend, the drop likely reflects net losses in certain quarters (e.g., Q4 FY2026) and possibly share repurchases that reduce equity. This volatility in retained earnings indicates that the equity base is not consistently growing, which may signal that the company is not yet generating sustainable profitability.

Despite the increase in debt, the current ratio has strengthened, indicating that current assets are more than sufficient to cover short-term liabilities. Cash levels have fluctuated but remain above $200M, which, combined with operating cash flow, provides a buffer for working capital needs and debt service. However, the elevated leverage means that liquidity could tighten if cash flows deteriorate, so investors should monitor the company's ability to generate consistent operating cash flow to service its debt.